Zimmer Hip Replacement Problems | Zimmer Hip Recall

Zimmer Durom Hip Problems – How they Differ from DePuy Hip Complications

Staff Writer | February 1st, 2011

Perhaps you’ve experienced Zimmer hip problems , or maybe a loved one has endured painful hip revision surgery. Or maybe you’ve just heard about the wave of hip replacement recalls currently slamming the orthopedic device industry. If so, you’re probably confused how Zimmer Durom Cup problems differ from DePuy ASR hip complications, and how the recalls and lawsuits may affect you. The following information contains those answers and the most essential facts at the center of the hip recalls.

Suspension of Zimmer Durom Cup Sales

Sales suspended:
July 2008 (Put back on the market with updated implant instructions several months later)

Hip Recipients Affected:
12,500 Durom Cup recipients in the US

The Problem:
Zimmer Holdings, one of the world’s largest orthopedic device manufacturers, didn’t think it had a problem. It took a respected surgeon to alert the company and the world to serious Durom Cup defects. In April 2008, Dr. Larry Dorr announced that more than 8 percent of the patients he fitted with a Durom Cup experienced hip implant failure and required revision surgery within 2 years. The device, which is designed to bond directly to the hip bone without a fixative or screws, was found to slip from the bone, sometimes popping free.

The Solution:
Zimmer’s solution to its Durom Cup problem was to halt sales of the device temporarily but remarket the device several months later with updated instructions for surgeons. Many of those surgeons still refuse to implant the device. For patients who received the device and experienced Durom hip complications, the solution might be filing a Zimmer lawsuit. Dozens of Durom Cup recipients have done so already.

DePuy ASR Hip Recall

Recall Date:
August 2010

Hip Recipients Affected:
More than 30,000 ASR recipients in the US, 90,000 worldwide

The Problem:
Last August, DePuy confirmed that its device failed in 12-13 percent of hip recipients within 5 years. A British study published earlier this year found failure rates as high as 50 percent after just 6 years. The ASR is supposed to last in excess of 15 years. But the metal-on-metal device has been shown to shed dangerous chromium and cobalt ions into the tissue, where it can destroy muscle; as well as into the bloodstream-, where it can cause potentially fatal blood poisoning.

The Solution:
More than one hundred DePuy hip lawsuits have been filed in federal courts across the United States. Thousands may be processed by the time the first trials take place this year or next. To settle legal costs associated with the DePuy recall, parent company Johnson & Johnson has set aside $922 million, much of which may go toward DePuy hip lawsuit settlements.